Experienced in Cavernous Sinus Thrombosis

Cecile Duvillard

Saint-priest-la-vetre, FR 
Experienced in Cavernous Sinus Thrombosis
Saint-priest-la-vetre, FR 
OverviewLocationsClinical Research

Overview

Cecile Duvillard practices in Saint-priest-la-vetre, France. Ms. Duvillard is rated as an Experienced expert by MediFind in the treatment of Cavernous Sinus Thrombosis. Her top areas of expertise are Pulmonary Embolism, Cavernous Sinus Thrombosis, Pulmonary Hypertension, and Venous Thromboembolism (VTE).

Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Cavernous Sinus Thrombosis.

Gender
Female

Locations

Saint-priest-la-vetre, 42270, France
Other Locations
Saint-etienne-de-valoux, 42270, France
Saint Étienne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.
Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.
Enrollment Status: Completed
Publish Date: December 05, 2022
Intervention Type: Drug
Study Phase: Phase 1
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Enrollment Status: Terminated
Publish Date: October 19, 2022
Intervention Type: Drug
Study Drugs: Apixaban, Rivaroxaban, Heparin, VKA
Study Phase: Phase 3
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Enrollment Status: Completed
Publish Date: August 25, 2022
Intervention Type: Other
View 3 Less Clinical Trials

8 Total Publications

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
Journal: International journal of molecular sciences
Published: August 06, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Duvillard's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile